Cizzle Brands Announces CWENCH Hydration is Now the Official Sport Drink of the NHL's Ottawa Senators

Cizzle Brands Announces CWENCH Hydration is Now the Official Sport Drink of the NHL's Ottawa Senators

Along with the designation of Official Sport Drink, under the three-year deal, Cizzle Brands and the Senators are collaborating to launch Powerplay Punch, a new LTO flavour of CWENCH Hydration™ that will be branded with the Senators name and logo.

Cizzle Brands Corporation (Cboe Canada: CZZL) (OTCQB: CZZLF) (Frankfurt: 8YF) ( the "Company" or "Cizzle Brands") , is pleased to announce that CWENCH Hydration is now the official sport drink of the National Hockey League's Ottawa Senators . As part of the three-year agreement (the " Agreement " ), CWENCH Hydration™ will also become the exclusive sports/isotonic drink sold in bottles, cans or Tetra Pak packaging at the Canadian Tire Centre (home arena for the Ottawa Senators) during pre-season, regular season, and playoff games for the Ottawa Senators and the Ottawa Black Bears (lacrosse) as well as at each of the Bell Sensplex and Richcraft Sensplex facilities.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250902625008/en/

CWENCH Hydration™ is now the Official Sports Drink of the NHL's Ottawa Senators. Along with the recognition, CWENCH will be launching a LTO flavour, Powerplay Punch, which will be sold in Canada's National Capital Region.

CWENCH Hydration™ is now the Official Sports Drink of the NHL's Ottawa Senators. Along with the recognition, CWENCH will be launching a LTO flavour, Powerplay Punch, which will be sold in Canada's National Capital Region.

In addition, Cizzle Brands will launch a limited time offering (" LTO ") flavour of CWENCH Hydration™ named Powerplay Punch in collaboration with the Senators featuring the team's logo and related insignia. The Company has received commitments to sell Powerplay Punch from retailers in the Canada's National Capital Region, including Sobeys , Healthy Planet , and Circle K (Ontario) .

The Agreement also provides Cizzle Brands with robust advertising rights for CWENCH Hydration, including:

  • LED display feature of CWENCH Hydration™ branded messaging throughout the Canadian Tire Centre at select pre-game and/or in-game times during 20 Ottawa Senators regular season home games;
  • Digitally enhanced dasherboards to be shown on television during every Ottawa Senators regular season away game broadcast by the Ottawa Senators regional broadcast rightsholder (currently TSN Network);
  • Presenting sponsorship of the Ottawa Senators' pre-game warm up on both social media and in-venue during every Ottawa Senators regular season home game played at the Canadian Tire Centre;
  • Presenting sponsorship of the Spring and Summer Youth Leagues played at the Bell Sensplex and Richcraft Sensplex facilities;
  • Title sponsorship of Hockey Fest , a two-day event held during the Bell Capital Cup tournament each year; and
  • Daily digital display advertising on the single screens at Bell Sensplex and Richcraft Sensplex.

The agreement with the Senators is Cizzle Brands' latest strategic sponsorship for driving visibility and awareness for CWENCH Hydration™ in the hockey world. It builds on the sponsorship agreement with Canlan Sports Ice Corp. for the naming rights for CWENCH Centre - a Canlan Sports Community , as well as Cizzle's agreement with USA Hockey , the governing body for the sport of ice hockey in the United States, to become USA Hockey's Official Hydration Partner . Several notable hockey players and personalities have also collaborated with CWENCH Hydration™ including Montreal Canadiens' winger Cole Caufield , NHL MVP and Colorado Avalanche forward Nathan MacKinnon, and hockey influencer Coach Chippy .

Cizzle Brands' Founder, Chairman, and Chief Executive Officer John Celenza commented, "The start of hockey season in Canada is a special time of year for hockey players, hockey fans of all ages, and for us at Cizzle Brands. So, it's great to be announcing this deal with the Senators, our first official agreement with an NHL team. The CWENCH Hydration™ brand has reached a key level of maturity, with a particularly strong presence in Canada's National Capital Region, which will only grow with the launch of Powerplay Punch. It is a pleasure to team up with the Ottawa Senators, for many exciting hockey seasons ahead."

About Cizzle Brands Corporation

Cizzle Brands Corporation is a sports nutrition company that is elevating the game in health and wellness. Through extensive collaboration and testing with leading athletes and trainers across several elite sports, Cizzle Brands has launched two leading product lines in the sports nutrition category: (i) CWENCH Hydration™, a better-for-you sports drink that is now carried in over 4,400 locations in Canada, the United States, and Europe; and (ii) Spoken Nutrition, a premium brand of athlete-grade nutraceuticals that carry the prestigious NSF Certified for Sport® qualification. All Cizzle Brands products are designed to help people achieve their best in both competitive sports and in living a healthy, vibrant, active lifestyle.

For more information about Cizzle Brands, please visit: https://www.cizzlebrands.com/

For more information about CWENCH Hydration™, please visit: https://www.cwenchhydration.com

About the Ottawa Senators

One of seven NHL franchises based in Canada, the Ottawa Senators returned to the league in 1992 following a 58-year absence. Ottawa won 11 Stanley Cups during its original reign from 1903 to 1934. The modern-day Senators have captured four titles in the Northeast Division and a Presidents' Trophy in 2002-03. Since 1992, the Senators together with its foundation, alumni, partners and fans have now contributed more than $100 million to community initiatives in the National Capital Region.

On behalf of the Board of Directors of the Company,

Cizzle Brands Corporation

"John Celenza"

John Celenza, Founder, Chairman, and Chief Executive Officer

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" which may include, but is not limited to, information with respect to the activities, events or developments that the Company expects or anticipates will or may occur in the future, such as, but not limited to: new products of the Company and potential sales and distribution opportunities. Such forward-looking information is often, but not always, identified by the use of words and phrases such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the Company.

Forward looking information involves known and unknown risks, uncertainties and other risk factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such risks include risks related to increased competition and current global financial conditions, access and supply risks, reliance on key personnel, operational risks, regulatory risks, financing, capitalization and liquidity risks. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company undertakes no obligation, except as otherwise required by law, to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors change.

Setti Coscarella
Head of Corporate Development
investors@cizzlebrands.com
1-844-588-2088

Ian Mendez
Vice-President, Communications in Media Relations
Mendesi@ottawasenators.com
613-599-0289

News Provided by Business Wire via QuoteMedia

CZZL:AQL
The Conversation (0)
Cizzle Brands Corporation (CBOE:CZZL)

Cizzle Brands Corporation

A Sports Nutrition Company Leading the Next Wave in Health and Wellness

A Sports Nutrition Company Leading the Next Wave in Health and Wellness Keep Reading...
BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT at ASCO 2026

BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT at ASCO 2026

Final Phase 2 Bria-IMT median overall survival (OS) is 16.6 months (with Phase 3 formulation) Positive Quality of Life (QOL) data from the ongoing Phase 3 study in heavily pre-treated metastatic breast cancer (MBC) patientsBiomarker analyses from the ongoing Phase 3 study confirm predictors of... Keep Reading...
Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7

Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7

KELOWNA, BC / ACCESS Newswire / May 19, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug delivery platforms, is pleased to announce that ethics approval has been received from an independent review board, for Human Pilot Study #7... Keep Reading...
BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+

BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+

BriaCell expands push in women's health, building on Phase 2 success in advanced metastatic breast cancerBria-OVA+, BriaCell's next generation personalized immunotherapy candidate for ovarian cancer, is designed with additional immune-stimulating components to support enhanced anti-tumor... Keep Reading...
BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+ for Prostate Cancer

BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+ for Prostate Cancer

Bria-PROS+ is BriaCell's next generation personalized off-the-shelf immunotherapy for prostate cancerImmune stimulating components of Bria-PROS+ enhance anti-tumor responsesBriaCell has completed manufacturing clinical supplies of Bria-PROS+ and plans to initiate a Phase 1/2a clinical study in... Keep Reading...
BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

Other recently activated sites include Indiana University Melvin and Bren Simon Comprehensive Cancer Center, University of Virginia (UVA) Comprehensive Cancer Center, Baptist Health South Florida, and SCRI Oncology Partners briacell therapeutics corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) ("BriaCell"... Keep Reading...
Glowing DNA strand against blue background with digital graphs and glowing bars.

Hantavirus Outbreak Sparks Rollercoaster Ride for Biotech Stocks

A localized hantavirus outbreak aboard an Atlantic cruise ship triggered a brief, speculative frenzy in biotechnology stocks this week.Shares of prominent vaccine developers fluctuated on Monday (May 11) as retail investors attempted to front run what they perceived as a burgeoning global health... Keep Reading...

Interactive Chart

Latest Press Releases

Related News